Pharmacovigilance Global Market Report 2026

Description

Pharmacovigilance is the science and practice of identifying, evaluating, understanding, and mitigating side effects and other issues related to drugs or vaccines. It helps determine whether a medication's benefits outweigh its risks and continues beyond the point of drug approval.

The main types of pharmacovigilance include spontaneous reporting, intensified ADR reporting, targeted spontaneous reporting, cohort event monitoring, and EHR mining. Spontaneous reporting is a passive method that relies on individuals to voluntarily report suspected adverse drug reactions to local or national pharmacovigilance centers. Key process flows involve case data management, signal detection, and risk management systems. Service providers can be in-house or contracted for outsourcing, covering clinical trial phases such as preclinical, Phase I, Phase II, Phase III, and Phase IV. These services are utilized by hospitals, pharmaceutical companies, and other healthcare organizations.

Tariffs have moderately impacted the pharmacovigilance market by increasing the cost of imported IT infrastructure, data management software, and specialized safety monitoring tools used across global operations. These cost pressures particularly affect contract outsourcing providers and EHR mining segments, with Asia-Pacific and parts of Europe experiencing higher operational expenses due to reliance on cross-border technology services. Clinical trial phase IV activities and advanced signal detection processes are also influenced by delayed system upgrades. However, tariffs have encouraged local deployment of pharmacovigilance platforms, regional service partnerships, and investment in domestic data processing capabilities, supporting long-term market resilience.

The pharmacovigilance market research report is one of a series of new reports from The Business Research Company that provides pharmacovigilance market statistics, including pharmacovigilance industry global market size, regional shares, competitors with a pharmacovigilance market share, detailed pharmacovigilance market segments, market trends and opportunities, and any further data you may need to thrive in the pharmacovigilance industry. This pharmacovigilance market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The pharmacovigilance market size has grown rapidly in recent years. It will grow from $9.64 billion in 2025 to $10.86 billion in 2026 at a compound annual growth rate (CAGR) of 12.7%. The growth in the historic period can be attributed to increasing adverse drug reaction reporting, expansion of global pharmaceutical approvals, rising clinical trial volumes, establishment of international drug safety regulations, growth in chronic disease drug usage.

The pharmacovigilance market size is expected to see rapid growth in the next few years. It will grow to $17.41 billion in 2030 at a compound annual growth rate (CAGR) of 12.5%. The growth in the forecast period can be attributed to real-world data utilization growth, rising biologics and biosimilars approvals, increasing complexity of combination therapies, expansion of pharmacovigilance in emerging markets, growing focus on patient safety outcomes. Major trends in the forecast period include expansion of post-marketing surveillance activities, growing adoption of real-world evidence in safety monitoring, increasing regulatory scrutiny and compliance requirements, rising outsourcing of pharmacovigilance services, integration of multisource safety data platforms.

The increasing research and development (R&D) activities are expected to drive the growth of the pharmacovigilance market. By investing in R&D, pharmaceutical companies can develop new drugs with improved safety profiles. Rigorous preclinical and clinical testing during drug development enables the early identification of potential safety concerns, allowing for the implementation of effective risk mitigation strategies. Additionally, R&D supports the advancement of technologies for adverse event monitoring, data analysis, and signal detection, facilitating the timely identification of adverse drug reactions in the post-marketing phase. For instance, in 2023, according to the Office for National Statistics, a UK-based government agency, the UK government's net spending on R&D increased to £17.4 billion in 2023, up from £16.1 billion in 2022, marking an 8.2% rise. Therefore, increasing R&D activities are fueling the growth of the pharmacovigilance market.

Key companies in the pharmacovigilance market are leveraging artificial intelligence (AI) to improve operational efficiency and accuracy. AI streamlines pharmacovigilance processes, enhances data management, accelerates signal detection, and ultimately contributes to better patient safety and outcomes. For example, in August 2024, the Government of India launched the Adverse Drug Reaction Monitoring System (ADRMS) software, introduced by the Minister of Health & Family Welfare and the Minister of Chemicals and Fertilizers. This pharmacovigilance platform facilitates the collection and analysis of adverse events related to medicines and medical devices, simplifying the reporting process for healthcare professionals and consumers. ADRMS strengthens India's pharmacovigilance infrastructure by ensuring comprehensive safety data capture, enhancing regulatory compliance, and supporting the country's position in the global pharmaceutical industry.

In January 2023, AmerisourceBergen, a US-based pharmaceutical wholesale company, acquired Pharma Lex for an undisclosed amount. This acquisition expands AmerisourceBergen's capabilities in supporting pharmaceutical and biotechnology companies across the product lifecycle. Pharma Lex, a Germany-based company, provides end-to-end pharmacovigilance solutions, including systems and operations management as well as benefit-risk assessment services, enhancing the overall safety monitoring infrastructure for its clients.

Major companies operating in the pharmacovigilance market are IQVIA, Cognizant, ICON Plc, Accenture plc, PAREXEL International Corporation, United BioSource LLC, ArisGlobal, Quanticate, Wipro Limited, Linical Americas, Novotech CRO, EXTEDO, Arriello, PrimeVigilance, Axios International, C3i Solutions, Secure AI Labs, OmniSol dot Tech, Prevnos Inc., Lifescient Inc, QuintilesIMS, Labcorp Drug Development, Pharmaceutical Product Development Inc., PRA Health Sciences, Synowledge LLC, RAPAhub, illuminate health, Invenio Medical, ClinChoice Inc., Novasyte, Fortrea Holdings Inc., Syneos Health Clinical, Telerx Marketing Inc.

North America was the largest region in the pharmacovigilance market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast region. The regions covered in the pharmacovigilance market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the pharmacovigilance market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The pharmacovigilance market includes revenues earned by collecting, analyzing, monitoring, and preventing adverse effects in drugs and therapies. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Pharmacovigilance Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses pharmacovigilance market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on end user analysis.
Benchmark performance against key competitors based on market share, innovation, and brand strength.
Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for pharmacovigilance ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The pharmacovigilance market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

Markets Covered:1) By Type: Spontaneous Reporting; Intensified ADR Reporting; Targeted Spontaneous Reporting; Cohort Event Monitoring; EHR Mining
2) By Service Provider: In-House; Contract Outsourcing
3) By Process Flow: Case Data Management; Signal Detection; Risk Management System
4) By Clinical Trial Phases: Preclinical; Phase I; Phase II; Phase III; Phase IV
5) By End User: Hospitals; Pharmaceutical Companies; Other End Users
Subsegments:
1) By Spontaneous Reporting: Individual Case Safety Reports (ICSRs); Voluntary Reporting Systems; Case Reports From Healthcare Professionals
2) By Intensified ADR Reporting: Active Surveillance Programs; Enhanced Monitoring In Clinical Trials; Risk Minimization Strategies
3) By Targeted Spontaneous Reporting: Reporting For Specific Drug Classes; Condition-Specific Reporting; Focused Surveillance Programs
4) By Cohort Event Monitoring: Prospective Cohort Studies; Retrospective Cohort Studies; Longitudinal Studies
5) By EHR Mining: Data Extraction From Electronic Health Records; Signal Detection Through EHR Analysis; Integration Of EHR Data With Pharmacovigilance Systems
Companies Mentioned: IQVIA; Cognizant; ICON Plc; Accenture plc; PAREXEL International Corporation; United BioSource LLC; ArisGlobal; Quanticate; Wipro Limited; Linical Americas; Novotech CRO; EXTEDO; Arriello; PrimeVigilance; Axios International; C3i Solutions; Secure AI Labs; OmniSol dot Tech; Prevnos Inc.; Lifescient Inc; QuintilesIMS; Labcorp Drug Development; Pharmaceutical Product Development Inc.; PRA Health Sciences; Synowledge LLC; RAPAhub; illuminate health; Invenio Medical; ClinChoice Inc.; Novasyte; Fortrea Holdings Inc.; Syneos Health Clinical; Telerx Marketing Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report
+ Excel Dashboard
Added Benefits
Bi-Annual Data Update
Customisation
Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Product Code: PH3MPHAR02_G26Q1

1. Executive Summary

1.1. Key Market Insights (2020-2035)
1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
1.3. Major Factors Driving the Market
1.4. Top Three Trends Shaping the Market

2. Pharmacovigilance Market Characteristics

2.1. Market Definition & Scope
2.2. Market Segmentations
2.3. Overview of Key Products and Services
2.4. Global Pharmacovigilance Market Attractiveness Scoring And Analysis
- 2.4.1. Overview of Market Attractiveness Framework
- 2.4.2. Quantitative Scoring Methodology
- 2.4.3. Factor-Wise Evaluation
Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation
2.4.5. Strategic Implications and Recommendations

3. Pharmacovigilance Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem
3.2. List Of Key Raw Materials, Resources & Suppliers
3.3. List Of Major Distributors and Channel Partners
3.4. List Of Major End Users

4. Global Pharmacovigilance Market Trends And Strategies

4.1. Key Technologies & Future Trends
- 4.1.1 Artificial Intelligence & Autonomous Intelligence
- 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
- 4.1.3 Biotechnology, Genomics & Precision Medicine
- 4.1.4 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
- 4.1.5 Industry 4.0 & Intelligent Manufacturing
4.2. Major Trends
- 4.2.1 Expansion Of Post-Marketing Surveillance Activities
- 4.2.2 Growing Adoption Of Real-World Evidence In Safety Monitoring
- 4.2.3 Increasing Regulatory Scrutiny And Compliance Requirements
- 4.2.4 Rising Outsourcing Of Pharmacovigilance Services
- 4.2.5 Integration Of Multisource Safety Data Platforms

5. Pharmacovigilance Market Analysis Of End Use Industries

5.1 Pharmaceutical Companies
5.2 Hospitals
5.3 Biotechnology Companies
5.4 Contract Research Organizations
5.5 Academic And Research Institutes

6. Pharmacovigilance Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Pharmacovigilance Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Pharmacovigilance PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
7.2. Global Pharmacovigilance Market Size, Comparisons And Growth Rate Analysis
7.3. Global Pharmacovigilance Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
7.4. Global Pharmacovigilance Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Pharmacovigilance Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)
8.2. Methodology and Assumptions
8.3. Global Total Addressable Market (TAM) Estimation
8.4. TAM vs. Current Market Size Analysis
8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Pharmacovigilance Market Segmentation

9.1. Global Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring, EHR Mining
9.2. Global Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
In-House, Contract Outsourcing
9.3. Global Pharmacovigilance Market, Segmentation By Process Flow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Case Data Management, Signal Detection, Risk Management System
9.4. Global Pharmacovigilance Market, Segmentation By Clinical Trial Phases, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Preclinical, Phase I, Phase II, Phase III, Phase IV
9.5. Global Pharmacovigilance Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Hospitals, Pharmaceutical Companies, Other End Users
9.6. Global Pharmacovigilance Market, Sub-Segmentation Of Spontaneous Reporting, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Individual Case Safety Reports (ICSRs), Voluntary Reporting Systems, Case Reports From Healthcare Professionals
9.7. Global Pharmacovigilance Market, Sub-Segmentation Of Intensified ADR Reporting, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Active Surveillance Programs, Enhanced Monitoring In Clinical Trials, Risk Minimization Strategies
9.8. Global Pharmacovigilance Market, Sub-Segmentation Of Targeted Spontaneous Reporting, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Reporting For Specific Drug Classes, Condition-Specific Reporting, Focused Surveillance Programs
9.9. Global Pharmacovigilance Market, Sub-Segmentation Of Cohort Event Monitoring, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Prospective Cohort Studies, Retrospective Cohort Studies, Longitudinal Studies
9.10. Global Pharmacovigilance Market, Sub-Segmentation Of EHR Mining, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Data Extraction From Electronic Health Records, Signal Detection Through EHR Analysis, Integration Of EHR Data With Pharmacovigilance Systems

10. Pharmacovigilance Market Regional And Country Analysis

10.1. Global Pharmacovigilance Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
10.2. Global Pharmacovigilance Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Pharmacovigilance Market

11.1. Asia-Pacific Pharmacovigilance Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
11.2. Asia-Pacific Pharmacovigilance Market, Segmentation By Type, Segmentation By Service Provider, Segmentation By Process Flow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Pharmacovigilance Market

12.1. China Pharmacovigilance Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
12.2. China Pharmacovigilance Market, Segmentation By Type, Segmentation By Service Provider, Segmentation By Process Flow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Pharmacovigilance Market

13.1. India Pharmacovigilance Market, Segmentation By Type, Segmentation By Service Provider, Segmentation By Process Flow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Pharmacovigilance Market

14.1. Japan Pharmacovigilance Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
14.2. Japan Pharmacovigilance Market, Segmentation By Type, Segmentation By Service Provider, Segmentation By Process Flow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Pharmacovigilance Market

15.1. Australia Pharmacovigilance Market, Segmentation By Type, Segmentation By Service Provider, Segmentation By Process Flow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Pharmacovigilance Market

16.1. Indonesia Pharmacovigilance Market, Segmentation By Type, Segmentation By Service Provider, Segmentation By Process Flow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Pharmacovigilance Market

17.1. South Korea Pharmacovigilance Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
17.2. South Korea Pharmacovigilance Market, Segmentation By Type, Segmentation By Service Provider, Segmentation By Process Flow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Pharmacovigilance Market

18.1. Taiwan Pharmacovigilance Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
18.2. Taiwan Pharmacovigilance Market, Segmentation By Type, Segmentation By Service Provider, Segmentation By Process Flow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Pharmacovigilance Market

19.1. South East Asia Pharmacovigilance Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
19.2. South East Asia Pharmacovigilance Market, Segmentation By Type, Segmentation By Service Provider, Segmentation By Process Flow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Pharmacovigilance Market

20.1. Western Europe Pharmacovigilance Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
20.2. Western Europe Pharmacovigilance Market, Segmentation By Type, Segmentation By Service Provider, Segmentation By Process Flow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Pharmacovigilance Market

21.1. UK Pharmacovigilance Market, Segmentation By Type, Segmentation By Service Provider, Segmentation By Process Flow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Pharmacovigilance Market

22.1. Germany Pharmacovigilance Market, Segmentation By Type, Segmentation By Service Provider, Segmentation By Process Flow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Pharmacovigilance Market

23.1. France Pharmacovigilance Market, Segmentation By Type, Segmentation By Service Provider, Segmentation By Process Flow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Pharmacovigilance Market

24.1. Italy Pharmacovigilance Market, Segmentation By Type, Segmentation By Service Provider, Segmentation By Process Flow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Pharmacovigilance Market

25.1. Spain Pharmacovigilance Market, Segmentation By Type, Segmentation By Service Provider, Segmentation By Process Flow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Pharmacovigilance Market

26.1. Eastern Europe Pharmacovigilance Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
26.2. Eastern Europe Pharmacovigilance Market, Segmentation By Type, Segmentation By Service Provider, Segmentation By Process Flow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Pharmacovigilance Market

27.1. Russia Pharmacovigilance Market, Segmentation By Type, Segmentation By Service Provider, Segmentation By Process Flow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Pharmacovigilance Market

28.1. North America Pharmacovigilance Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
28.2. North America Pharmacovigilance Market, Segmentation By Type, Segmentation By Service Provider, Segmentation By Process Flow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Pharmacovigilance Market

29.1. USA Pharmacovigilance Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
29.2. USA Pharmacovigilance Market, Segmentation By Type, Segmentation By Service Provider, Segmentation By Process Flow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Pharmacovigilance Market

30.1. Canada Pharmacovigilance Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
30.2. Canada Pharmacovigilance Market, Segmentation By Type, Segmentation By Service Provider, Segmentation By Process Flow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Pharmacovigilance Market

31.1. South America Pharmacovigilance Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
31.2. South America Pharmacovigilance Market, Segmentation By Type, Segmentation By Service Provider, Segmentation By Process Flow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Pharmacovigilance Market

32.1. Brazil Pharmacovigilance Market, Segmentation By Type, Segmentation By Service Provider, Segmentation By Process Flow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Pharmacovigilance Market

33.1. Middle East Pharmacovigilance Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
33.2. Middle East Pharmacovigilance Market, Segmentation By Type, Segmentation By Service Provider, Segmentation By Process Flow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Pharmacovigilance Market

34.1. Africa Pharmacovigilance Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
34.2. Africa Pharmacovigilance Market, Segmentation By Type, Segmentation By Service Provider, Segmentation By Process Flow, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Pharmacovigilance Market Regulatory and Investment Landscape

36. Pharmacovigilance Market Competitive Landscape And Company Profiles

36.1. Pharmacovigilance Market Competitive Landscape And Market Share 2024
- 36.1.1. Top 10 Companies (Ranked by revenue/share)
36.2. Pharmacovigilance Market - Company Scoring Matrix
- 36.2.1. Market Revenues
- 36.2.2. Product Innovation Score
- 36.2.3. Brand Recognition
36.3. Pharmacovigilance Market Company Profiles
- 36.3.1. IQVIA Overview, Products and Services, Strategy and Financial Analysis
- 36.3.2. Cognizant Overview, Products and Services, Strategy and Financial Analysis
- 36.3.3. ICON Plc Overview, Products and Services, Strategy and Financial Analysis
- 36.3.4. Accenture plc Overview, Products and Services, Strategy and Financial Analysis
- 36.3.5. PAREXEL International Corporation Overview, Products and Services, Strategy and Financial Analysis

37. Pharmacovigilance Market Other Major And Innovative Companies

United BioSource LLC, ArisGlobal, Quanticate, Wipro Limited, Linical Americas, Novotech CRO, EXTEDO, Arriello, PrimeVigilance, Axios International, C3i Solutions, Secure AI Labs, OmniSol dot Tech, Prevnos Inc., Lifescient Inc

38. Global Pharmacovigilance Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Pharmacovigilance Market

40. Pharmacovigilance Market High Potential Countries, Segments and Strategies

40.1 Pharmacovigilance Market In 2030 - Countries Offering Most New Opportunities
40.2 Pharmacovigilance Market In 2030 - Segments Offering Most New Opportunities
40.3 Pharmacovigilance Market In 2030 - Growth Strategies
- 40.3.1 Market Trend Based Strategies
- 40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations
41.2. Currencies
41.3. Historic And Forecast Inflation Rates
41.4. Research Inquiries
41.5. The Business Research Company
41.6. Copyright And Disclaimer